FDG PET imaging of myxofibrosarcoma on the sphenoid sinus

Clinical Nuclear Medicine

Volumn 33, Issue 6, 2008, Pages 421-422

  Enomoto, Keisuke ^a,b   Inohara, Hidenori ^b   Hamada, Kenichiro ^a   Tamura, Manabu ^b   Tomita, Yasuhiko ^c   Kubo, Takeshi ^b   Hatazawa, Jun ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Otolaryngology and Sensory Organ Surgery ^*  (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

FDG; Myxofibrosarcoma; PET; Sarcoma; Sphenoid sinus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; FIBROMYXOSARCOMA; FIBROSARCOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; POSITRON EMISSION TOMOGRAPHY; SPHENOID SINUS; METHODOLOGY; PARANASAL SINUS TUMOR; SCINTISCANNING;

AGED; FIBROSARCOMA; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; PARANASAL SINUS NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPHENOID SINUS;

EID: 46349108815     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318170d51a     Document Type: Article

References (8)

1. Johnson GR, Zhuang H, Khan J, et al. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma. Clin Nucl Med. 2003;28:815-820.
2. Hamada K, Tomita Y, Ueda T, et al. Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors. Ann Nucl Med. 2006;20:671-675.
3. Hayasaka K, Nihashi T, Matsuura T, et al. Metastasis of the gastrointestinal tract: FDG-PET imaging. Ann Nucl Med. 2007;21:361-365.
4. Kobayashi E, Kawai A, Seki K, et al. Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: value of [F-18]FDG PET-CT for diagnosis of occult metastases. Ann Nucl Med. 2006;20:695-698.
5. Weckesser E, Redeker J, Kühnel G, et al. Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography. Nuklearmedizin. 2000;39:N38-N39.
6. Nishimura G, Sano D, Hanashi M, et al. Myxofibrosarcoma of the hypopharynx. Auris Nasus Larynx. 2006;33:93-96.
7. Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer. 1977;39:1672-1685.
8. Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand. 1977;85A:127-140.